Figure 3.

The expression of MAGED4B and FJX1 in 5 most common cancers.

(A) Western blot analysis showed the expression of 2 target antigens in cell lines including lung (A549), prostate (PC3), colorectal (HT-29, HCT-116) and breast (SKBR-3, MCF-7). Lysates from ORL-195 overexpressing MAGED4B and HeLa/T overexpressing FJX1 were used as positive controls for the western blot analyses. RNA-seq data for (B) MAGED4B and (C) FJX1 expression in 5 most common cancers comparing to head and neck cancer data sets derived from TCGA (BRCA: breast invasive carcinoma, PRAD: prostate adenocarcinoma, COAD: colon adenocarcinoma, READ: rectal adenocarcinoma, LUAD: lung adenocarcinoma, LUSC: lung squamous carcinoma, HNSC: head and neck squamous carcinoma). The symbol * denotes p value < 0.05, while ** denotes that p value < 0.001.